Supplementary Figure 4 from Resistance to Selective FGFR Inhibitors in <i>FGFR-</i>Driven Urothelial Cancer

<p>Expression of FGFR3:TACC3 was homogeneous across Ba/F3 cell lines.</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Francesco Facchinetti (16827090) (author)
Altres autors:	Antoine Hollebecque (15010338) (author), Floriane Braye (16827093) (author), Damien Vasseur (16827096) (author), Yoann Pradat (15352227) (author), Rastislav Bahleda (16617234) (author), Cédric Pobel (16617263) (author), Ludovic Bigot (16617254) (author), Olivier Déas (16827099) (author), Juan David Florez Arango (16827102) (author), Giorgia Guaitoli (16827105) (author), Hayato Mizuta (16827108) (author), David Combarel (16827111) (author), Lambros Tselikas (15019536) (author), Stefan Michiels (9081965) (author), Sergey I. Nikolaev (15061686) (author), Jean-Yves Scoazec (15036392) (author), Santiago Ponce-Aix (16827114) (author), Benjamin Besse (15061674) (author), Ken A. Olaussen (16827117) (author), Yohann Loriot (15123021) (author), Luc Friboulet (15025943) (author)
Publicat:	2025
Matèries:	Cancer Therapeutic Research and Development Drug Resistance Clinical drug resistance Reversal of drug resistance Drug Targets Protein kinase & phosphatase drug targets Genitourinary Cancers Bladder cancer
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars